• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
α,β-Dihydroresveratrol

α,β-Dihydroresveratrol

Product ID D3331
Cas No. 58436-28-5
Purity ≥99%
Product Unit SizeCostQuantityStock
5 mg $113.00 In stock
10 mg $183.00 In stock
25 mg $380.00 In stock
100 mg $1,127.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

α,β-Dihydroresveratrol is a polyphenol found in many food sources and is a major metabolite of resveratrol. α,β-dihydroresveratrol may have better bioavailability than its parent compound. α,β-dihydroresveratrol may be involved in resveratrol’s anticancer chemotherapeutic and chemopreventive activities and also may modulate voltage-gated K+ channels.

Product Info

Cas No.

58436-28-5

Purity

≥99%

Formula

C14H14O3

Formula Wt.

230.26

Chemical Name

a, b-Dihydro-3,4',5'-trihydroxystilbene

IUPAC Name

5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol

Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

D3331 MSDS PDF

Info Sheet

D3331 Info Sheet PDF

Brochures

Resveratrol Flyer

References

Bode LM, Bunzel D, Huch M, et al. In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. Am J Clin Nutr. 2013 Feb;97(2):295-309. PMID: 23283496.

Alfaras I, Juan ME, Planas JM. trans-Resveratrol reduces precancerous colonic lesions in dimethylhydrazine-treated rats. J Agric Food Chem. 2010 Jul 14;58(13):8104-10. PMID: 20521815.

Orsini F, Verotta L, Lecchi M, et al. Resveratrol derivatives and their role as potassium channels modulators. J Nat Prod. 2004 Mar;67(3):421-6. PMID: 15043422.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • P8382

    Puupehenone

    Sesquiterpene found in marine sponges.

    ≥94%
  • F1854

    Fenticonazole Nitrate

    Imidazole; 14-α demethylase inhibitor, potenti...

    ≥98%
  • F1853

    Fenofibrate

    Fibrate; PPARα agonist.

    ≥98%
  • O7992

    OTX-015

    BRD2/3/4 inhibitor.

    ≥98%
  • K0023

    K252c

    Staurosporine analog; PKC and PKA inhibitor.

    ≥98%
  • O1179

    n-Octyl-4-methylcaffeate

    Derivative of methyl caffeate, hydroxycinnamic ...

    ≥98%
  • G2873

    Growth Hormone Releasing Factor, sheep

    Endogenous peptide hormone, involved in growth ...

    ≥95%
  • P0005

    Pituitary Adenylate Cyclase-activating Polypeptide (1-27), human, sheep, rat

    Endogenous peptide, involved in paracrine and a...

    ≥95%
  • T1012

    13-TES-Baccatin III

    Synthesis impurity

    ≥98%
  • F4584

    Fluphenazine Hydrochloride

    Piperazine; FIASMA, D2 antagonist, hERG K+ chan...

    ≥97%
  • C822706

    Curvularin

    Macrocyclic lactone.

    ≥98%
  • T7034

    Trimethoprim

    Dihydrofolate reductase inhibitor.

    ≥98%
  • R2514

    RGDV

    Tretraeptide, binds cell surface integrins.

    ≥98%
  • M2409

    MGCD-0103

    HDAC inhibitor.

    ≥98%
  • T0114

    Taxinin M

    Taxane found in Taxus; DNA polymerase inhibitor...

    ≥98%
  • V1872

    Vesicular Stomatitis Virus Peptide

    Peptide fragment of VSV; LDLR agonist.

    ≥95%
  • P2810

    Phenylbutazone

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • C0048

    Cambinol

    SIRT inhibitor.

    ≥98%
  • R1806

    Rebamipide

    Quinolone, antioxidant.

    ≥98%
  • G124090

    GDC-6036

    KRAS inhibitor

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only